Total Funding
74
69
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
222656
HAWA Therapeutics creates a novel treatment for muscle strain, damage, and dystrophy stimulating muscle stem cell functions.
About the Company
HAWA Therapeutics creates a novel treatment for muscle strain, damage, and dystrophy stimulating muscle stem cell functions. The treatment involves injecting HIF2ai inhibitors into the muscle, but the company is also exploring topical and oral approaches.
Moderate and severe muscle strains can cause immense pain, causing people to be out of work
for long periods of time. Treatment options are limited to physical therapy, surgery, and a host of short-term drugs such as anti-inflammatories. Severe strains often heal incompletely, making people susceptible to further injury.
HAWA’s HIF2Ai technology accelerates initial recovery and reduces recurrent injuries by preventing the formation of scar tissue.
